Showing results (1671-1680 of 2,429) with videos related to
Sort By:
Pageof 243
Diabetologia|March 11, 2022
Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities studyJustin B Echouffo-Tcheugui, Natalie Daya, Chiadi E Ndumele, et al.The American Journal of Cardiology|February 7, 2009
Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemiaAnne C Goldberg, Harold E Bays, Christie M Ballantyne, et al.International Journal of Cardiology|April 17, 2015
Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort StudyJohn W McEvoy, Mariana Lazo, Yuan Chen, et al.Archives of Internal Medicine|March 8, 2003
Risk for myopathy with statin therapy in high-risk patientsChristie M Ballantyne, Alberto Corsini, Michael H Davidson, et al.Atherosclerosis|February 22, 2012
The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) StudyVijay Nambi, Eric Boerwinkle, Kim Lawson, et al.Circulation|June 1, 1994
Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heartK A Youker, H K Hawkins, G L Kukielka, et al.Journal of Clinical Lipidology|January 29, 2013
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier diseaseSmita I Negi, Ariel Brautbar, Salim S Virani, et al.Clinical Biochemistry|November 20, 2013
Three-year variability in plasma concentrations of the soluble receptor for advanced glycation end products (sRAGE)Julie K Bower, James S Pankow, Mariana Lazo, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 23, 2014
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities studyCasey M Rebholz, Brad C Astor, Morgan E Grams, et al.Cells|June 10, 2022
Poloxamer 407 Induces Hypertriglyceridemia but Decreases Atherosclerosis in Ldlr-/- MiceXueying Peng, Zeqin Lian, Xiao-Yuan Dai Perrard, et al.Pageof 243